Reflection Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Reflection Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$107K	Buy	+1,978	New	+$95.2K	0.08%	152

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Reflection Asset Management's BMY Position: Q4 2025 in Review

Reflection Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2025: 1,978 shares worth $107K. The stake represents 0.08% of the portfolio and ranks #152 among its holdings.

2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Reflection Asset Management held 1,978 shares of Bristol-Myers Squibb worth $107K as of Q4 2025.
Bristol-Myers Squibb was a new Reflection Asset Management position in Q4 2025.
Bristol-Myers Squibb made up 0.08% of Reflection Asset Management's portfolio in Q4 2025, its #152 holding.
2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Reflection Asset Management's 13F filing for Q4 2025, filed 2 Mar 2026.